Jack Mycka

Vice president, pricing, reimbursement, and market access (PRMA), and emerging biotech commercialization, MME, an Indegene PRMA business

Articles

Policy Reforms for Orphan Drugs

Outlook for orphan PRMA environment in the US, EU4, and UK.